MARBOCARE FLAVOUR 5MG TABLETS FOR DOGS AND CATS

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

MARBOFLOXACIN

Available from:

Emdoka bvba

ATC code:

QJ01MA93

INN (International Name):

MARBOFLOXACIN

Dosage:

5 Milligram

Pharmaceutical form:

Tablets

Prescription type:

POM

Therapeutic group:

Canine, Feline

Therapeutic area:

Marbofloxacin

Therapeutic indications:

Antibacterial

Authorization status:

Authorised

Authorization date:

2013-09-20

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Marbocare flavour 5mg tablets for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Tablet
Beige brown spotted round tablets with a score line on one side.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Marbofloxacin is indicated in the treatment of the following infections caused by susceptible strains of organisms (see
section 5.1);
Dogs
Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis)
Urinary tract infections (UTI) associated or not with prostatitis or epididymitis
Respiratory tract infections
Cats
Skin and soft tissue infections (wounds, abscesses, phlegmons)
Upper respiratory tract infections
4.3 CONTRAINDICATIONS
Do not use in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as
Great Danes, Briard, Bernese, Bouvier and Mastiffs, with a longer growth period.
Not recommended for use in cats aged less than 16 weeks.
Do not use in animals with known hypersensitivity to marbofloxacin or other (fluoro)quinolones or to any of the
excipients.
Do not use in case of confirmed or suspected resistance to fluoroquinolones (cross resistance).
EACH TABLET CONTAINS:
ACTIVE SUBSTANCE: Marbofloxacin
5.0 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 20/09/2013_
_CRN 7013116_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
A low urinary pH could have an inhibitory effect on the activity of marbofloxacin.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN AN